However, the lack of specificity with CXCL9/10 with other renal pathologies, such as infection and acute kidney injury, highlight the need for multiple markers, such as exosomal mRNA, along with clinical contexts, to potentially guide clinical decisions. This evidence concerns the gene CXCL9 and infection.